Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Cancers
|
May 6, 2020
Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen
Sugandha Bhatia, Tony Blick, Cletus Pinto, et al.
Plos One
|
March 29, 2013
Proteomic biomarkers for ageing the mosquito Aedes aegypti to determine risk of pathogen transmission
Leon E Hugo, James Monkman, Keyur A Dave, et al.
NPJ Precision Oncology
|
May 12, 2026
Dissecting non-small cell lung cancer (NSCLC) with blood proteomics-from surgical to immunotherapeutic responses
Vahid Yaghoubi Naei, Aaron Kilgallon, Gwendoline Mendes, et al.
Journal of Translational Medicine
|
July 25, 2024
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
Habib Sadeghirad, James Monkman, Chin Wee Tan, et al.
ACS Sensors
|
June 5, 2024
A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue
Karthik B Shanmugasundaram, Emtiaz Ahmed, Xinzhe Miao, et al.
Frontiers in Immunology
|
May 8, 2023
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
Habib Sadeghirad, Ning Liu, James Monkman, et al.
Nature Communications
|
February 3, 2026
Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC)
James Monkman, Aaron Kilgallon, Clara Lawler, et al.
Genome Medicine
|
October 8, 2025
Cell-cell interactions as predictive and prognostic markers for drug responses in cancer
Xuehan Lu, Xiao Tan, Eun Ju Kim, et al.
Nature Genetics
|
October 10, 2025
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer
Thazin N Aung, James Monkman, Jonathan Warrell, et al.
Journal of Translational Medicine
|
February 12, 2025
Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response
Vahid Yaghoubi Naei, Rafael Tubelleza, James Monkman, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Cancers
|
May 6, 2020
Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen
Sugandha Bhatia, Tony Blick, Cletus Pinto, et al.
Plos One
|
March 29, 2013
Proteomic biomarkers for ageing the mosquito Aedes aegypti to determine risk of pathogen transmission
Leon E Hugo, James Monkman, Keyur A Dave, et al.
NPJ Precision Oncology
|
May 12, 2026
Dissecting non-small cell lung cancer (NSCLC) with blood proteomics-from surgical to immunotherapeutic responses
Vahid Yaghoubi Naei, Aaron Kilgallon, Gwendoline Mendes, et al.
Journal of Translational Medicine
|
July 25, 2024
Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response
Habib Sadeghirad, James Monkman, Chin Wee Tan, et al.
ACS Sensors
|
June 5, 2024
A Mesoporous Gold Sensor Unveils Phospho PD-L1 in Extracellular Vesicles as a Proxy for PD-L1 Expression in Lung Cancer Tissue
Karthik B Shanmugasundaram, Emtiaz Ahmed, Xinzhe Miao, et al.
Frontiers in Immunology
|
May 8, 2023
Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy
Habib Sadeghirad, Ning Liu, James Monkman, et al.
Nature Communications
|
February 3, 2026
Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC)
James Monkman, Aaron Kilgallon, Clara Lawler, et al.
Genome Medicine
|
October 8, 2025
Cell-cell interactions as predictive and prognostic markers for drug responses in cancer
Xuehan Lu, Xiao Tan, Eun Ju Kim, et al.
Nature Genetics
|
October 10, 2025
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancer
Thazin N Aung, James Monkman, Jonathan Warrell, et al.
Journal of Translational Medicine
|
February 12, 2025
Spatial interaction mapping of PD-1/PD-L1 in head and neck cancer reveals the role of macrophage-tumour barriers associated with immunotherapy response
Vahid Yaghoubi Naei, Rafael Tubelleza, James Monkman, et al.
Page
of 5